Results 131 to 140 of about 32,786 (220)

Systemic Light Chain Amyloidosis [PDF]

Systemic light chain (AL) amyloidosis is a rare protein misfolding and deposition disorder. Clonal plasma cells or rarely B cells produce immunoglobulin light chains with the potential to misfold.
Minnema, Monique, Schönland, Stefan
core  

Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis ARTICLE

, 2020
P atients with immunoglobulin light chain amyloidosis are at risk for both thrombotic and bleeding complications. While the hemostatic defects have been extensively studied, less is known about thrombotic complications in this disease. This retrospective
Fangui Sun, Luke I Masha, J Mark Sloan, Vaishali Sanchorawala, John L Berk, Andrea Havasi, Katherine M Bever, Lauren Stern, David C Seldin   +8 more
core  

Concurrent Therapy for Immunoglobulin Light Chain Cardiac Amyloidosis and Transthyretin Cardiac Amyloidosis

Internal Medicine
Cardiac amyloidosis (CA), predominantly caused by amyloid transthyretin (ATTR) or immunoglobulin light chain (AL), has a poor prognosis, and a precise diagnosis is crucial because the optimal treatments differ between the two conditions. However, diagnosing AL-CA is challenging because of the unavailability of effective AL-detecting antibodies ...
Horigome, Yuichi, Ishii, Shunsuke, Matsumoto, Manabu, Ikeda, Yoshihiko, Hatakeyama, Kinta, Ako, Junya, Suzuki, Takahiro   +6 more
openaire   +3 more sources

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

American journal of hematology/oncology, 2005
M. Gertz, R. Comenzo, R. Falk, J. Fermand, B. Hazenberg, P. Hawkins, G. Merlini, P. Moreau, P. Ronco, V. Sanchorawala, O. Sezer, A. Solomon, G. Grateau   +12 more
semanticscholar   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Diagnosing Light Chain Amyloidosis on Temporal Artery Biopsies for Suspected Giant Cell Arteritis

, 2017
Although still rarely diagnosed, amyloid light chain (AL) amyloidosis is the most common form of systemic amyloidosis. It is characterized by misfolded monoclonal immunoglobulin light chain fragments that accumulate extracellularly as amyloid fibrils ...
Rosanna A. M. Ghinai; Shameem Mahmood; Pinias Mukonoweshuro; Sally Webber; Ashutosh D. Wechalekar; Sally E. Moore
core  

Treatment of Immunoglobulin Light Chain Amyloidosis [PDF]

Mayo Clinic Proceedings, 2015
Angela Dispenzieri, Francis Buadi, Shaji K. Kumar, Craig B. Reeder, Tamur Sher, Martha Q. Lacy, Robert A. Kyle, Joseph R. Mikhael, Vivek Roy, Nelson Leung, Martha Grogan, Prashant Kapoor, John A. Lust, David Dingli, Ronald S. Go, Yi Lisa Hwa, Suzanne R. Hayman, Rafael Fonseca, Sikander Ailawadhi, P. Leif Bergsagel, Ascher Chanan-Khan, S. Vincent Rajkumar, Stephen J. Russell, Keith Stewart, Steven R. Zeldenrust, Morie A. Gertz   +25 more
openaire   +1 more source

A case of pulmonary transthyretin amyloidosis with concurrent mycobacterial tuberculosis infection

Respirology Case Reports
Amyloidosis is a pathological deposition disease that causes a spectrum of organ dysfunction. Pulmonary involvement is generally associated with immunoglobulin light chain type (AL) amyloid. Transthyretin (ATTR) amyloid build up in the lung is thought to
Hanson Siu, Ari Mond, James Shaw, Ruth Chin, Patrick Hosking, Hari Wimaleswaran   +5 more
doaj   +1 more source

Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis. [PDF]

Front Immunol, 2022
Yan J, Zhao J, Ning X, Qin Y, Xing Y, Wang Y, Jia Q, Huang B, Ma R, Lei C, Zhou M, Yu Z, Zhang Y, Guo WF, Sun S.   +14 more
europepmc   +1 more source